Patrick J Heron's Net Worth

$206 Thousand

Who is Patrick J Heron?

Patrick J Heron does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Vaxcyte, Inc., Trubion Pharmaceuticals, Inc, Tarsus Pharmaceuticals, Inc., GLAUKOS Corp, ALPINE IMMUNE SCIENCES, INC., COLLEGIUM PHARMACEUTICAL, INC, Phathom Pharmaceuticals, Inc., Arcutis Biotherapeutics, Inc., ANAPTYSBIO INC, Imago BioSciences, Inc., Sierra Oncology, Inc., Mirum Pharmaceuticals, Inc., Frazier Lifesciences Acquisition Corp, Cidara Therapeutics, Inc., Entasis Therapeutics Holdings Inc., Iterum Therapeutics plc, Passage BIO, Inc., Aptinyx Inc., HilleVax, Inc., and Regado Biosciences Inc.

SEC CIK

Patrick J Heron's CIK is 0001365617

Past Insider Trading and Trends

2020 was Patrick J Heron's most active year for acquiring shares with 5 total transactions. Patrick J Heron's most active month to acquire stocks was the month of May. 2010 was Patrick J Heron's most active year for disposing of shares, totalling 5 transactions. Patrick J Heron's most active month to dispose stocks was the month of September. 2006 saw Patrick J Heron paying a total of $172,250.00 for 12,500 shares, this is the most they've acquired in one year. In 2021 Patrick J Heron cashed out on 15,000 shares for a total of $0.00, their largest year based on trade value.